Profile: Cannabis Council of Canada
The Cannabis Council of Canada (C3) is the national and international voice for Canada’s licensed cannabis producers and processors, advocating for a safe, competitive, and responsible industry. We promote high standards, foster economic growth, and work to ensure integrity within the regulated market. By advocating for fair regulations, high-quality standards, and economic opportunities, we work to ensure public safety, and foster a legal market that benefits communities, businesses, and consumers alike. Committed to eliminating the illicit market, we strive to strengthen Canada’s legal cannabis sector while driving innovation and economic opportunities. As the trusted national resource on the Canadian Cannabis industry, we engage with stakeholders to support the industry’s continued development and responsible use for both medical and recreational purposes.
The mission of the Cannabis Council of Canada is to advocate for and promote a healthy, trusted, and competitive cannabis market that empowers Canada’s Licensed Producers to deliver high-quality, rigorously tested products to consumers while ensuring long-term financial sustainability.
The C3 Advocacy Roadmap
C3’s mission in 2026 is built on three specific pillars of reform aimed at stabilizing the sector:
The 10% Ad Valorem Cap: C3 is lobbying to replace the $1-per-gram minimum with a hard cap at 10% of the producer’s selling price. This would immediately restore margins and allow legal producers to compete fairly on price.
National Stamp Harmonization: Currently, producers must navigate a logistical nightmare of province-specific excise stamps. C3 is pushing for a single national stamp to streamline supply chains and reduce operational costs.
The Medical Exemption: A renewed effort to eliminate excise tax on medical cannabis, ensuring that patients aren’t taxed for accessing their medication.
The Cannabis Council is committed to advancing the interests of its members by providing essential industry resources, engaging with policymakers to shape fair and progressive regulations, and championing policies that encourage sector growth while reducing unnecessary operational and financial burdens.
Through collaboration with industry stakeholders, government bodies, and the public, the Council fosters an environment where innovation, consumer safety, and responsible business practices drive the future of Canada’s legal cannabis industry.
For more information please visit: https://www.cannabis-council.ca/
Report: Global Medical Cannabis 2026-2030
The Global Medical Cannabis Market Review examines the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets.
Published by Prohibition Partners, the report provides country-specific data and analysis, comparing countries based on relevant metrics including volumes of exports and imports, market size, domestic production, product and distribution landscape.
Prohibition Partners was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world. This report includes market sizing and patient population forecasts for 14 key international markets – from 2026-2030. Also included is graphical and narrative analysis of the market size and the driving forces behind growth. In addition, scenario forecasting for Australia & Germany will also be included.
The Review delves deeper into the driving forces behind international import and supply chain dynamics, as well as factors such as: domestic production capabilities in various countries, the impact of telemedicine on patient access and care, and recent regulatory changes that shape the landscape of medical cannabis. By analysing these elements, the Review aims to offer insights into market growth potential and the evolving global context of medical cannabis supply and demand.
For more information about this report, including a 45-page free download, visit:
https://prohibitionpartners.com/reports/global-medical-cannabis-market-review-2026/
Profile: C-45 Quality Association
The C-45 Quality Association is committed to advancing excellence in Canada’s cannabis industry by promoting quality production practices, fostering sustainable and inclusive growth, and driving innovation. Through education, industry events, and strategic partnerships, we provide platforms for knowledge-sharing, professional development, and networking. We educate and inform consumers, producers, and regulators about the benefits of high standards, host events that bring together industry leaders and emerging voices, and offer resources that empower professionals at all levels to thrive. Our mission is to build a collaborative and resilient industry that reflects the highest quality, integrity, and continuous learning.
The Association strives to protect the public interest by engaging its members in the cannabis industry to arrive at sound practices that strengthen the industry and ensure safe and effective cannabis management throughout all of Canada, and globally, as the industry matures. The Association also endeavours to provide members with access to valuable knowledge, networks and resources that will assist members in improving and advancing their careers.
For more information please visit: https://www.cannabis-council.ca/
Canada’s Cannabis Sector Contributes $11.6 Billion to National GDP
Recent economic data from Stratcann and other sources indicates that the cannabis industry continues to be a significant driver of the Canadian economy.
In 2025, the sector’s total contribution to the national GDP reached approximately $11.6 billion. Notably, the licensed production and processing segment accounted for the vast majority of this impact, contributing $10.6 billion. This represents a steady increase over previous years, highlighting the industry’s maturation and its role as a more substantial economic contributor than several other traditional agricultural and beverage sectors.
The data underscores the long-term viability of the sector and provides a factual basis for ongoing discussions regarding industry regulation and economic policy. Licensed production now contributes more to the national GDP than industries such as air transportation and meat product manufacturing.
The data is primarily derived from Statistics Canada. The 11.6 billion dollar figure for 2025 is based on real-time and monthly gross domestic product data tracked by industry. These figures are calculated using chained 2017 dollars to provide a consistent comparison over time across various economic sectors. Another major source for these figures is a comprehensive economic study released in September 2025 titled High Impact, Green Growth: The Economic Footprint of Canada’s Cannabis Industry. This report was a collaborative effort between the Business Data Lab at the Canadian Chamber of Commerce and Organigram Global. While the study found an even higher total economic impact of 16 billion dollars when including indirect and induced effects, it used the raw underlying data provided by Statistics Canada to perform its modeling.
Framework for Clinical Trials: Government of Canada Consultation
Health Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals, biologics and radiopharmaceuticals) and on multiple guidance documents related to the proposal. The proposed framework would replace the clinical trial regulatory schemes for drugs in the following sections of the regulations:
Part C, Division 5 of the Food and Drug Regulations and
Part 2 of the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations
This proposed framework aims to improve access to new and innovative therapies for people in Canada while maintaining strong safety protections for participants.
This initiative is part of Health Canada and the Public Health Agency of Canada’s work to streamline processes and enhance regulatory efficiency.
The consultation is open until March 20, 2026.
- For more information visit: Government of Canada
- To read a legal discussion about this visit: Pharmain Brief
- To read the official announcement visit: Government of Canada Gazette
Profile: AQIC (Association québécoise de l'industrie du cannabis)
With over 120 members, the Quebec Hemp and Cannabis Industry Association (AQIC) is committed to working with government and stakeholders to advance the Quebec hemp and cannabis industry to its full potential and encourage innovation through science and technology.
The AQIC provides a space to share information and reflect upon common challenges and opportunities. The Association was founded in 2019, on the principle that we can accomplish more together. And by working together as one voice, we can advance our common goals of raising the bar on a safe and sustainable industry in Quebec.
The association’s mission is to represent the Quebec hemp and cannabis industry and contribute in a constructive and responsible manner to its development.
The AQIC also plays an educational role by educating the general public about hemp and cannabis consumption. We also monitor and analyze current policies, advocate for changes in the cannabis and hemp legislation and provide recommendations to provincial and federal government officials.
For more information please visit: https://aqic.ca/
CCX Bulk Wholesale Cannabis Pricing Report
The Canadian Cannabis Exchange (CCX), a privately held cannabis exchange, has released a new report with cannabis pricing data.
The report provides settled pricing data on wholesale cannabis flower, trim, extracts, and genetics. The data for this report comes from the 2025 records of GCX and its subsidiary, the Canadian Cannabis Exchange (CCX), which operates a cannabis wholesale trading platform.
Stratcann, Canada’s cannabis media and events platform, reviewed the report and wrote, “Entering 2026, the Canadian wholesale cannabis market is expected to be more volatile and competitive due to rapid supply growth, moderating domestic demand, and rising global competition…”
To read the Stratcann review of the report visit: https://stratcann.com/news/2025-canadian-wholesale-cannabis-pricing-and-2026-market-outlook/
To learn more about this report and download a sample visit: https://canadiancannabisx.com/product/2025-ccx-bulk-wholesale-cannabis-pricing-report/
Pivoting After Health Canada’s CBD NHP Ruling
Why the Medical Channel is Now the Primary Path for CBD
The start of 2026 has brought a significant shift for the Canadian cannabis industry. In a move that surprised many stakeholders, Health Canada recently removed the long-awaited proposal for Natural Health Products (NHPs) containing CBD from its forward regulatory plan. For years, producers and consumers alike hoped for a “third stream” for CBD—one that would allow non-intoxicating cannabidiol to be sold on pharmacy shelves and in health food stores alongside vitamins and supplements. With that pathway now effectively stalled, the industry must pivot.
Here is what the removal of the CBD NHP proposal means for your business and how you can navigate this “Medical-First” landscape.
What Happened?
On January 8, 2026, industry news outlets reported that the regulatory framework designed to create a “pathway for health products containing cannabidiol” had been stripped from the government’s upcoming agenda. This follows years of consultations that began back in 2019.
Is the Medical Channel the Only Way Forward?
For producers focused on the wellness and therapeutic benefits of CBD, the answer is increasingly “yes.” Without an NHP pathway, CBD remains locked behind the same regulatory requirements as THC.
However, this isn’t necessarily a setback—it’s a clarification of the market. The Medical Cannabis Channel remains the only legal way for producers to provide CBD to patients with professional healthcare oversight and without the “recreational” stigma of the adult-use retail environment.
How AirMed Supports Your Pivot to Medical
If your business strategy relied on CBD NHPs, now is the time to double down on your medical sales infrastructure. AirMed was built from the ground up to support the complex requirements of medical cannabis sales in Canada.
1. The AirMed WordPress Medical Plugin
Your website needs to be more than a digital brochure; it needs to be a secure patient portal. Our WordPress Medical Plugin allows you to:
- Manage Patient Registration: Streamline the intake of medical documents and healthcare practitioner (HCP) authorizations.
- Secure Product Catalogs: Show your CBD-dominant products only to verified medical clients, ensuring you stay compliant with strict promotion and advertising regulations.
2. Encrypted Patient Messaging
Health-focused CBD consumers often have more questions than recreational users. AirMed provides secure, encrypted messaging between your staff and your clients, allowing you to provide high-touch customer service while protecting sensitive patient data.
3. Seamless Fulfillment & Shipping
Transitioning to a direct-to-patient model requires a robust logistics engine. AirMed integrates directly with carriers and fulfillment tools (like ShipStation) to ensure that your wellness-focused clients receive their CBD products discreetly and efficiently.
The Bottom Line
The removal of the CBD NHP proposal from the 2026 regulatory plan is a reminder of the volatility of the Canadian regulatory environment. However, the demand for high-quality, health-focused CBD has never been higher. By leveraging the Medical Channel, producers can bypass the uncertainty of the NHP path and start serving patients today.
Official Context: You can monitor the current Health Canada Forward Regulatory Plan for updates here: https://www.canada.ca/en/health-canada/corporate/about-health-canada/legislation-guidelines/acts-regulations/forward-regulatory-plan.html
Industry Commentary: StratCann reported that this move leaves CBD strictly under the Cannabis Act, rather than the Natural Health Products Regulations: https://stratcann.com/news/health-canada-removes-cbd-nhp-regulation-proposal-from-forward-regulatory-plan/
And for a demonstration of our medical plugin in action, please visit: https://airmeddemo.com/
The Rise of Craft and Quality: A Reflection on 2025
As the calendar turns from 2025 to 2026, it’s a natural time to pause and reflect on the evolution of our industry. This year has not only marked another milestone since legalization but has also demonstrated a profound shift in consumer expectations. We are moving past the initial phase of simply supplying volume; the market is maturing, demanding more sophistication and quality than ever before. This reflection leads us directly to the single most compelling growth strategy for the coming year: embracing the niche for premium, craft cannabis.
The Shift from Bulk to Boutique
Seven years into legalization, the Canadian cannabis consumer is no longer a novice. Consumers are sophisticated, educated, and increasingly selective. This maturation has fundamentally changed the domestic market, shifting the focus away from volume and toward quality, novelty, and differentiation.
While large producers compete on price in the value segment; smaller, nimble producers can find profitability in the premium craft segment. Consumers are demonstrating a willingness to pay a premium for products that offer a superior experience, unique strain profiles, and transparent production ethics.
Survival in 2026 requires more than just a licence; it requires a “Craft” badge. Provinces like Ontario (OCS) have set strict criteria for this designation, which micros are uniquely positioned to meet. By meeting these standards, micros can charge a premium that offsets their higher cost-of-production compared to “Standard” producers who rely on machine-trimming and volume.
The Craft Advantage
Recent regulatory adjustments by Health Canada are directly enabling this shift by reducing red tape and empowering smaller operators through expanded micro licensing, co-packing and flexible labelling.
To capitalize on the demand for craft and quality, producers should focus on:
- Cultivation Excellence: Embrace traditional, hands-on methods such as hand-trimming, hang-drying, and specialized curing processes that preserve terpene profiles and visual appeal.
- Genetics and Uniqueness: Differentiate your brand by cultivating rare or unique genetics that can’t be found on every store shelf. Consumer loyalty is built on exceptional, repeatable experiences.
- Authentic Storytelling: Consumers want to know where their product comes from. Be transparent about your grow methods, your team, and the care that goes into each batch. This authenticity fosters trust and commands a premium price point.
The era of undifferentiated, mass-market cannabis is fading. The future belongs to the producers who are committed to quality and who understand that, in a competitive market, craftsmanship is the ultimate differentiator.
To read more about the micro movement in Canada, read this article on the Stracann website: https://stratcann.com/news/micros-continue-to-be-the-most-popular-cannabis-licence-type-in-2025/
AirMed was designed for just such craftsmanship and commitment to quality. For more information visit our Software page.
And for information on our micro licensing programme visit: https://www.airmedmicro.com/
Profile: Ontario Cannabis Association
The Ontario Cannabis Association (OCA) is a non-profit organization that represents licensed producers and processors in the province. The association’s mission is to be a collective voice for its members, working to strengthen the cannabis industry in Ontario using the guiding principles: Unite, Advocate, and Elevate.
The OCA’s work is based on several key pillars:
Advocacy: It actively champions the interests of its members by engaging with government officials and the Ontario Cannabis Store (OCS) to influence policy and regulation.
Collaboration: The association fosters partnerships with other organizations, including the Ontario Farmers Association and legacy market participants, to help them transition into the legal market.
Business Support: The OCA facilitates networking and knowledge-sharing among its members and leverages its relationships with suppliers to secure exclusive benefits and discounts.
Quality Assurance: The organization is developing a quality assurance labeling system to distinguish its members’ products and promote high standards of business practices and product quality.
The association is working to build a more inclusive, diverse, and economical cannabis industry in Ontario while ensuring the long-term success of its members and establishing a trusted and reputable legal market.
For more information please visit:
https://www.ontariocannabisassociation.ca/
Beyond Borders: Positioning Canadian Cannabis for the Global Export Market
The Global Opportunity: Why Canadian Cannabis is Primed for Export Growth
Canada has long held a first-mover advantage in the global cannabis ecosystem. Since federal legalization, Canadian producers have established world-class cultivation and processing standards that are highly valued on the international stage. As more countries open their doors to medical cannabis—particularly in Europe, Australia, and Israel—exporting is becoming a vital strategy for those looking to diversify revenue and mitigate challenges in the saturated domestic market.
The demand for pharmaceutical-grade cannabis continues to rise globally. For Canadians, the international stage is not just a secondary market; it’s a critical component of long-term economic sustainability.
Bridging the Compliance Gap: From Health Canada to the World
While Health Canada’s licensing is the foundation, accessing most international markets requires an extra layer of compliance, most notably Good Manufacturing Practices (GMP) certification. The critical points in this process are as follows.
- Certification: For producers targeting Europe, obtaining EU-GMP certification or an equivalent international standard (such as IMC GAP/GACP) is essential. This signals to global buyers that your product meets the strict quality assurance and control standards required for medical products.
- Leverage Quality: Canadian-produced cannabis is often seen as a premium product. Producers should lean into this advantage by emphasizing specialized genetics, consistency, and stability testing, which are paramount for long-term supply contracts.
- Strategic Partnerships: Working with GMP-certified distributors, logistics experts, and experienced global consultants can streamline the complex process of international customs, tariffs, and differing regulatory requirements across jurisdictions.
By intentionally building an export-ready operation today, Canadian producers can move beyond domestic competition and solidify their role as reliable, high-quality suppliers in the expanding global market. The time to look outward is now.
AirMed was designed for export markets and meets GMP and GACP standards.
For more information visit our Software page.
Or visit our Compliance page.
Report: Canada's Cannabis Sector is Mainstream
Seven years after legalization, the cannabis industry has fully integrated into Canadian society, moving from niche to mainstream consumer choice according to a new report. A national survey by Abacus Data reveals that not only is use widespread, but Canadians across the political spectrum see the sector as a valuable economic engine and are ready to see regulations modernized to fuel its growth.
According to the survey, Cannabis is part of everyday life. The data clearly shows that cannabis use is no longer a subculture. More than one in three Canadian adults report using cannabis in the past six months, with that number rising to 50% for those under 45. Cannabis is being consumed in diverse forms, with 25% of Canadians using edibles recently. Notably, the preference for cannabis is challenging alcohol: 30% of users say they prefer cannabis over alcohol, with another 29% viewing the two equally.
Canadians view the legal cannabis industry as a significant economic contributor, with a strong majority of 59% agreeing it’s important to the national economy. This perspective holds true across regions and political affiliations. This broad support translates into a clear message for policymakers.
Canadians are looking for the federal government to move beyond simple compliance and focus on growth. When asked about priorities, respondents want economic departments (like Industry or Agriculture) involved in policy decisions (47%) and tougher enforcement against the illegal market (43%).
There is also strong public appetite for emerging product categories. A majority (57%) is open to federal investment in the growth of new products like cannabis beverages, edibles, and wellness items.
Looking toward the future, over 70% of Canadians view the creation of tens of thousands of new domestic jobs and Canada becoming a global leader in wellness-focused cannabis products as a positive outcome.
The Abacus Data report concludes that the legal cannabis industry has a solid social license and visible economic value.
Abacus Data is a Canadian polling and market research firm based in Ottawa, Ontario.
For more on this report visit: https://abacusdata.ca/cannabis-is-mainstream-public-support-is-strong-and-canadians-want-the-sector-to-grow/
Profile: Alberta Cannabis Micro Licence Association
The Alberta Cannabis Micro Licence Association (ACMLA) is a non-profit organization that provides a unified voice for small-scale cannabis producers in Alberta. The association’s membership is comprised of micro-license holders, applicants, and other industry supporters.
The ACMLA’s mission is centered on advocacy, education, and collaboration. The group works directly with all levels of government to support the growth of the province’s craft cannabis sector. Key goals include shaping the industry’s future through policy reform, promoting low-cost sales channels like farm-gate operations, and reducing barriers for new entrants. The association also focuses on improving business practices and quality control for its members by sharing resources and best practices.
Beyond industry support, the ACMLA aims to foster broader economic opportunities, such as promoting cannabis tourism within Alberta. The association is also dedicated to combating the stigma surrounding cannabis through evidence-based education. By uniting its members, the ACMLA strives to create a more competitive and vibrant cannabis landscape that benefits small producers and the broader community.
For more information please visit:
https://acmla.ca/
Deloitte Report: Six Years of Legalization
The industry analysts at Deloitte have released a new report titled Six Years of Legalization: The Economic and Social Impact of Canada’s Cannabis Sector. This report examines the industry’s economic contribution from legalization through 2024, with a focus on both Ontario and the broader Canadian economy. The report finds that over the six-year period, the industry invested $42.0 billion in capital expenditures, and generated $28.7 billion in sales nationwide, primarily driven by the sales of recreational cannabis products.
Read more about the report here: https://www.deloitte.com/ca/en/Industries/consumer-products/research/an-industry-makes-its-mark.html
Profile: BC Cannabis Alliance
The BC Cannabis Alliance (BCCA) is a non-profit organization that serves as a collective voice for British Columbia’s licensed craft cannabis producers. Rooted in the province’s tradition of high-quality, small-batch cannabis, the BCCA advocates for a sustainable and thriving industry that supports rural economies and creates skilled jobs.
The alliance operates on a cooperative model, with a mission to help maintain BC’s status as a global leader in cannabis innovation. It works to provide small and medium-sized producers with a safe, legal, and sustainable alternative to the illicit market. Key goals include accelerating market access, establishing a retail network for its members, and achieving economies of scale to ensure these producers can compete with larger corporations.
A core function of the BCCA is government advocacy. The organization works to reform provincial and federal policies by addressing issues like excessive taxation, regulatory burdens, and competition from the unregulated market. It actively pushes for changes such as a more equitable excise tax structure, direct delivery reporting reforms, and grants for cannabis manufacturing. By championing causes like fair farm status exemptions and aligning licensing fees with other agricultural sectors, the BCCA aims to create a more supportive environment for BC’s craft cannabis industry.
For more information including how you can help, visit:
https://www.bccannabisalliance.com/
Profile: Canadian Cannabis Tourism Alliance
The Canadian Cannabis Tourism Alliance (CCTA) is at the forefront of establishing Canada as the world’s premier cannabis tourism destination. This dynamic organization comprises business owners, advocates, and cannabis professionals united by a common goal: to build a vibrant and sustainable cannabis tourism industry nationwide.
The CCTA is actively engaged in advocating for crucial policy changes, pushing for regulations that would enable everything from cannabis sales at public events to the establishment of consumption lounges. Their forward-thinking approach, evident in their 2024 plan to position Canada as the global cannabis tourism hub, highlights their commitment to shaping a responsible and thriving sector.
Beyond advocacy, the CCTA fosters industry growth through education, partnership development, and facilitating new business opportunities. They’ve already showcased their dedication with events like the “420 Cannabis Tourism ExtravaGanja” in Niagara Falls in April 2025, demonstrating their practical efforts to bring cannabis tourism experiences to life for consumers and professionals alike.
For more information including how to join, visit:
https://www.canadiancannabistourism.com/
AirMed: Scalable Software for Your Cannabis Business
Last week we discussed building a scalable and sustainable business. Read the post here: Sustainably Scaling Your Cannabis Business.
Creating a cannabis business that is both scalable and sustainable is the best way to deal with an uncertain economy. One of the keys to scalability lies in having tools that can handle a varying volume of transactions, inventory, and data.
Our cannabis management software is designed with scalability in mind. Whether you’re a startup or a large enterprise, our platform grows with you.
Scaling up operations can mean more complex processes, such as adding new product lines, expanding to new locations, or hiring additional staff. AirMed lets you handle these complexities with ease. Features such as multi-location support, role-based access, and centralized reporting help you streamline processes and avoid bottlenecks.
AirMed manages every aspect of cultivation, processing, packaging, and distribution. We also offer quality management, workforce management, CRM and ERP-level functionality.
You can automate a series of tasks and assign them to different departments or users with activities cascading across the entire production cycle. Plan templates let you create formulas after completing the cultivation, drying and packaging of a successful batch. Our software automates inventory management and monitors stock levels in real-time to let you adjust to fluctuating demand.
With integrated tools for sales reporting, AirMed can provide data-driven insights to help you make smarter decisions. Whether it’s forecasting sales trends, identifying popular products, or tracking seasonal demand, data becomes even more valuable as the economy fluctuates.
Our system is module to let you add functionality if and when needed. We also offer flexible billing options, and we’re currently developing a lower-cost ‘lite’ version of AirMed to help micros. A limited feature set and simplified workflows will get your smaller operation up and running while ensuring that you meet compliance and stay within budget.
Investing in scalable software ensures that your business can handle changing demand, variable inventories, and flexible operations to set the stage for long-term success. With the right system in place, you can focus on your business, while knowing that your operations are efficient, compliant, and sustainable.
For more information visit our Software page or our Compliance page.
Sustainably Scaling Your Cannabis Business
As the cannabis industry fluctuates, businesses must be prepared to scale operations depending on demand. Building a scalable, but also sustainable, cannabis operation is about more than just sales or product. It’s about creating a foundation that allows your business to deal with varying volumes of transactions, inventory, and data without introducing inefficiencies or compliance risks. Your operations should be flexible enough to accommodate your current demands while being adaptable to whatever the future has in store.
Scaling Up
During upturns, your sales volume and inventory size will inevitably increase, so your operations must be able to handle that. Your production may become more complex as a result, and you may want to expand. Whether you’re adding new product lines, opening new facilities, or hiring additional staff, be conscious of overbuilding infrastructure in case of a downturn. If you do decide to invest, look for systems that will support long-term efficiency. And ensure that whatever you scale up can be scaled back if needed.
1. Increase operations incrementally or modularly. Add capacity in blocks based on actual demand, or partner with those who can provide what you lack to reduce up-front costs.
2. Maintain your cash flow and build reserves during growth phases to cushion slumps. Avoid overleveraging and watch your ‘burn rate.’ Scale in ways that don’t push your operating expenses to unsustainable levels.
3. Grow where you’re strongest. Deepen presence in high-margin, high-loyalty markets before chasing expansion. Defend your base by building brand equity and customer loyalty with retention strategies before aggressively acquiring new customers or markets.
4. Diversify selectively. If you want to diversify, offer a mix of premium and budget-friendly options to serve customers in both boom and bust conditions. If feasible, expand into sectors or geographies less exposed to fluctuations.
5. Invest in people, culture, and leadership. For long-term sustainability, hire selectively and cross-train to build a team that can wear multiple hats if needed. Encourage adaptability, learning, and resourcefulness. Create strong leaders, a key to weathering uncertainty.
Scaling Down
During a slow economy, the best way to deal with a situation that seems beyond your control is to ensure that you have control over everything you can.
1. Streamline operations and optimize cultivation to reduce waste and increase profits. For example, using data analysis on lighting, nutrients, and water usage can increase yield without compromising quality.
2. Prioritize high-margin products and markets. Evaluate strains, product formats (e.g., pre-rolls, vapes), and brands to determine which sell reliably and offer the healthiest margins. Increase or reduce efforts in specific markets depending on performance metrics.
3. Incentivize loyalty. Offer discounts, product education, or other incentives to existing clients and partners. Encourage pre-paid orders or early payment discounts to improve cash flow.
4. Communicate transparently. Be upfront with all stakeholders about the current conditions. Encourage ideas from frontline workers on efficiency and even company direction, and show investors you’re taking disciplined, strategic action.
5. Utilize scalable systems and tools. Your equipment, software and services should scale with your business needs. Discuss temporary options with your vendors such as reduction of services to control short-term costs while maintaining long-term relationships.
Conclusion
By staying agile and innovative, you can pivot quickly when needed. And by utilizing all available data, you can improve decision making throughout your operations. This will help you invest selectively in growth-enablers to give you the best return on investment (ROI) whatever the economy throws at you.
For more information visit our Software page or our Compliance page.
Profile: ABLE BC, the voice of BC’s cannabis stores
The Alliance of Beverage Licensees (ABLE BC) is the voice of British Columbia’s bars, pubs, and private liquor and cannabis stores.
A non-profit organization funded by membership dues, ABLE’s mission is to help British Columbia’s liquor and cannabis businesses succeed.
On behalf of the organization’s 1,000 members, ABLE BC works with all levels of government to create business-friendly policies and enhance private sector opportunities.
Headquartered in Vancouver, the association offers advocacy work, member benefits and discounts, and direct access to the latest industry information and policy expertise for cannabis retail members.
According to the organization’s website, ABLE BC “works hard every single day to advocate for your interests, protect your businesses, and help ensure the survival of the cannabis retail and private liquor industries.”
For more information and to sign up for ABLE BC’s free newsletter, visit:
https://ablebc.ca/
Streamlining Cannabis Inventory Management
Effective inventory management is crucial in the cannabis industry. With strict regulations governing everything from product tracking to distribution, any inefficiencies or inaccuracies can result in legal issues, loss of product, or lost revenue.
Cannabis businesses, whether cultivators, manufacturers, or retailers, are tasked with managing complex inventory systems that require real-time updates, accurate tracking, and compliance with provincial and federal laws. This is where cannabis management software can come into play.
Software that provides advanced inventory management functionality helps automate and streamline processes, while tracking every product, at every stage.
With features like barcode scanning and real-time inventory updates, cannabis businesses can gain a clear, up-to-date view of their inventory. This transparency helps to minimize human error and avoid overstocking or stockouts—both of which can have serious financial implications.
Inventory management can streamline processes like harvesting, trimming, packaging, and distribution, reducing resources. A good inventory management system can also detect shrinkage from spoilage, mislabelling or theft for better cost control and waste reduction.
Inventory data can be used to anticipate demand, plan crops, or shift production toward high-margin products. A producer can improve supply chain decisions and lead times for restocking. Meeting demands without delays and ensuring consistent availability across dispensaries or partners ultimately results in enhanced customer satisfaction.
While operational efficiency is the most obvious result of streamlining inventory management, by providing insights into trends and sales patterns, businesses can make data-driven decisions to optimize all processes and increase profits.
AirMed has been 100-percent Canadian owned and operated since it was created in 2014. Click the Request Demo button at the top of the page today to explore AirMed in a free walkthrough and learn what home-grown can do for you.
For more information about AirMed visit our Software page.